Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

629 ARTÍCULOS , VIENDO DEL 421 AL 435

The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease

Xiong YL, Meng T, Luo J, Zhang H.

Eur Neurol. 2021;84(1):6-15. doi: 10.1159/000513008. Epub 2021 Jan 21.

Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease

Zhang Y, Wang Y, Shi C, Shen M, Lu F.

Transl Neurodegener. 2021 Feb 1;10(1):6. doi: 10.1186/s40035-021-00230-9.

Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses

Zhuang QS, Meng L, Wang Z, Shen L, Ji HF.

J Alzheimers Dis. 2021;80(1):271-281. doi: 10.3233/JAD-201235.

Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

Rostamzadeh A, Schwegler C, Gil-Navarro S, Rosende-Roca M, Romotzky V, Ortega G, Canabate P, Moreno M, Schmitz-Luhn B, Boada M, Jessen F, Woopen C.

J Alzheimers Dis. 2021;80(2):601-617. doi: 10.3233/JAD-200484.

Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting

Kokkinou M, Beishon LC, Smailagic N, Noel-Storr AH, Hyde C, Ukoumunne O, Worrall RE, Hayen A, Desai M, Ashok AH, Paul EJ, Georgopoulou A, Casoli T, Quinn TJ, Ritchie CW.

Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945. doi: 10.1002/14651858.CD010945.pub2.

Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics

Zetterberg H, Blennow K.

Mol Neurodegener. 2021 Feb 19;16(1):10. doi: 10.1186/s13024-021-00430-x.

Genetics of Alzheimer's disease

König T, Stögmann E.

Wien Med Wochenschr. 2021 Sep;171(11-12):249-256. doi: 10.1007/s10354-021-00819-9. Epub 2021 Feb 22.

Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment

He B, Wang L, Xu B, Zhang Y; Alzheimer’s Disease Neuroimaging Initiative.

Neurosci Lett. 2021 May 29;754:135765. doi: 10.1016/j.neulet.2021.135765. Epub 2021 Mar 2.

ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease

Pereira Vatanabe I, Peron R, Mantellatto Grigoli M, Pelucchi S, De Cesare G, Magalhães T, Manzine PR, Figueredo Balthazar ML, Di Luca M, Marcello E, Cominetti MR.

Int J Mol Sci. 2021 Feb 28;22(5):2416. doi: 10.3390/ijms22052416.

Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial

Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN; SPRINT Research Group.

JAMA Neurol. 2021 May 1;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.

Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study

Liu G, Liu C, Qiu A; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2021 Jun 15;42(9):2931-2940. doi: 10.1002/hbm.25414. Epub 2021 Mar 19.

Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease

Kara F, Belloy ME, Voncken R, Sarwari Z, Garima Y, Anckaerts C, Langbeen A, Leysen V, Shah D, Jacobs J, Hamaide J, Bols P, Van Audekerke J, Daans J, Guglielmetti C, Kantarci K, Prevot V, Roßner S, Ponsaerts P, Van der Linden A, Verhoye M.

Neurobiol Aging. 2021 Jun;102:139-150. doi: 10.1016/j.neurobiolaging.2021.02.011. Epub 2021 Feb 22.

Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial

Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group.

Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3.

Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research

Moloney CM, Lowe VJ, Murray ME.

Alzheimers Dement. 2021 Sep;17(9):1554-1574. doi: 10.1002/alz.12321. Epub 2021 Apr 2.

Alzheimer's pathogenic mechanisms and underlying sex difference

Zhu D, Montagne A, Zhao Z.

Cell Mol Life Sci. 2021 Jun;78(11):4907-4920. doi: 10.1007/s00018-021-03830-w. Epub 2021 Apr 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias